Target intelligence / Profile preview

Protease substrates with P1 aromatic or positively charged residues

Molecular classification
Other, Enzyme substrate class
01

Overview

Protease substrates with P1 aromatic or positively charged residues refers to a broad classification of peptide sequences defined by the amino acid located at the P1 position, which is the residue immediately N-terminal to the scissile bond. This nomenclature, established by Schechter and Berger, identifies the primary determinant for the specificity of proteases as they bind to the enzyme's S1 pocket (Schechter & Berger, 1967). Substrates with P1 aromatic residues, such as Phenylalanine or Tyrosine, are typically cleaved by chymotrypsin-like serine proteases, which are involved in processes like digestion and the activation of inflammatory mediators (Hedstrom, 2002). Conversely, substrates with P1 positively charged residues, such as Arginine or Lysine, are the primary targets for trypsin-like proteases, which are essential for the blood coagulation cascade and the complement system (Rawlings et al., 2018). This term does not describe a single therapeutic target but rather a functional category of molecules used to characterize the activity of various enzymes. In clinical practice, pharmacological agents are designed to inhibit the specific proteases that act on these substrates—such as Thrombin or Factor Xa—to treat conditions like deep vein thrombosis or stroke.

Other names
P1-aromatic protease substratesP1-basic protease substratesTrypsin-like protease substratesChymotrypsin-like protease substratesS1-pocket specific substrates
02

Mechanism of action

Drugs typically target the proteases (e.g., Thrombin, Factor Xa, or the Proteasome) that recognize these specific P1 residues, inhibiting their catalytic activity to prevent the cleavage of physiological substrates.

03

Biological functions

ProteolysisBlood coagulationProtein catabolismSignal transductionApoptosis
04

Disease associations

ThrombosisInflammationCancerCardiovascular diseaseInfection
05

Safety considerations

Risk of major bleedingOff-target proteolysisSystemic toxicityGastrointestinal distress
06

Interacting drugs

Dabigatran

5 more in the full profile.

07

Biomarkers

D-dimerProthrombin time (PT)International Normalized Ratio (INR)Activated partial thromboplastin time (aPTT)

Beyond the preview

Go deeper on Protease substrates with P1 aromatic or positively charged residues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protease substrates with P1 aromatic or positively charged residues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call